Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing v3.6.3, indicating a software revision of the page. This reflects an update to the underlying version rather than changes to the study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This indicates a minor release of the site template or backend components for the study details page.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision: v3.6.2 is now displayed, replacing v3.6.0. This indicates a small maintenance update to the site's version tag used for rendering and change tracking, with no visible impact on study content or navigation.SummaryDifference0.0%

- Check42 days agoChange DetectedThe study record now indicates a Completed status and an expanded network of 49 locations. A new site in Dnipro, Ukraine has been added, and the city name for an existing location has been updated to Kropyvnytskyi (formerly Kirovohrad).SummaryDifference0.5%

- Check49 days agoChange DetectedRecruitment status now indicates enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label and revision note to v3.6.0.SummaryDifference0.3%

- Check56 days agoChange DetectedThe page's Revision label was updated from v3.5.4 to v3.5.5.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.